116 related articles for article (PubMed ID: 1914150)
1. Pharmacologically defined M1 and M2 muscarinic cholinergic binding sites in the cat's substantia nigra: development and maturity.
Nastuk MA; Graybiel AM
Brain Res Dev Brain Res; 1991 Jul; 61(1):1-10. PubMed ID: 1914150
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic localization and biochemical characteristics of M1 and M2 muscarinic binding sites in the striatum of the cat, monkey, and human.
Nastuk MA; Graybiel AM
J Neurosci; 1988 Mar; 8(3):1052-62. PubMed ID: 3346715
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
5. Ontogeny of M1 and M2 muscarinic binding sites in the striatum of the cat: relationships to one another and to striatal compartmentalization.
Nastuk MA; Graybiel AM
Neuroscience; 1989; 33(1):125-47. PubMed ID: 2601852
[TBL] [Abstract][Full Text] [Related]
6. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
7. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic localization of muscarinic cholinergic receptors in visual areas of cat brain: variations in sensitivity of N-[3H]methylscopolamine binding sites to carbachol and pirenzepine.
Cymerman U; Palacios JM; Cortés R; Skangiel-Kramska J
Neurosci Lett; 1987 Oct; 81(1-2):13-8. PubMed ID: 3696462
[TBL] [Abstract][Full Text] [Related]
9. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
10. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
Alonso R; Didier M; Soubrie P
J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
[TBL] [Abstract][Full Text] [Related]
11. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
Delmendo RE; Michel AD; Whiting RL
Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor stimulation increases the spontaneous [3H]GABA release in the rat substantia nigra through muscarinic receptors localized on striatonigral terminals.
Kayadjanian N; Gioanni H; Ménetrey A; Besson MJ
Neuroscience; 1994 Dec; 63(4):989-1002. PubMed ID: 7700520
[TBL] [Abstract][Full Text] [Related]
14. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
16. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions.
Besson MJ; Graybiel AM; Nastuk MA
Neuroscience; 1988 Jul; 26(1):101-19. PubMed ID: 2901690
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
Cortés R; Palacios JM
Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.
Freedman SB; Beer MS; Harley EA
Eur J Pharmacol; 1988 Oct; 156(1):133-42. PubMed ID: 3208836
[TBL] [Abstract][Full Text] [Related]
19. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
Dauphin F; Hamel E
J Pharmacol Exp Ther; 1992 Feb; 260(2):660-7. PubMed ID: 1738116
[TBL] [Abstract][Full Text] [Related]
20. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
Lazareno S; Buckley NJ; Roberts FF
Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
